We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Atlas of Genes Helps Identify New Treatment Targets in Breast Cancer

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Salk Institute for Biological Studies, have generated the first single cell resolution atlas of genes that control the formation of breast tissue. The atlas provides a comprehensive molecular map that will be used to help researchers understand how breast cancers form and to pinpoint new ways to prevent, diagnose, and treat the disease. The findings were published in Cell Reports. The study was led by Benjamin Spike, PhD, an HCI cancer researcher and assistant professor of oncological sciences at the U of U.

Scientists have recognized the relationship between normal organ development and cancer for more than 100 years. "We know that cancers are driven by mutations in specific genes that cause cells to multiply or to survive where they don't belong," said Spike. "During this process, cancer cells misappropriate whole circuitries of cell biology that are important and normal at other times in development. Our team works to understand this process by researching how cells normally work to form tissues. We also identify developmental programs that have been taken over by cancers. Some of these programs should make good targets for treating or preventing disease, even if they are not directly mutated."

Until recently, tools didn't exist that could simultaneously and individually analyze all of the different types of cells in an organ and their active genes, the segments of cellular DNA that encode functional molecules such as proteins.

Working with the lab of Geoffrey Wahl, PhD, professor at the Salk Institute, and others, Spike and his team isolated breast cells from mice during different stages of breast tissue development. The researchers then used new genome sequencing technology to analyze which genes are turned on and off in more than 6,000 individual cells during normal development. This approach revealed a list of hundreds of potentially critical genes for further study as regulators of normal and cancerous development. These genes may provide targets for certain breast cancers that don't have molecular targeted therapies.

"This research promises new targets for these cancers, including genes involved in specialized cellular metabolism that are shared between early breast development and certain breast cancers," said Spike. The data from the study gives new insights about the organizing principles of tissues and the molecular definitions of the cell types comprising them. The research shows that breast cells in early development that are not fully differentiated into mature cell types activate more genes, resulting in mixed profiles and expression of some genes in unexpected breast cell types.

With this new data resource, researchers are now working to determine how these genes and pathways promote cancer and identify new drugs to block them.

This article has been republished from materials provided byHuntsman Cancer Institute (HCI). Note: material may have been edited for length and content. For further information, please contact the cited source.